Is your clinical trial AI racist?
We dive into the critical issue of racial bias in AI, highlighted by a recent Yale study focusing on ChatGPT. This has significant implications for clinical research sponsors, sites, and principal investigators. We also explore the FDA's perspective on AI in clinical trials, presented by Dr. Elzarrad.Overview of the Yale Study:The Yale study found that ChatGPT demonstrates racial bias in its responses, raising concerns about the use of AI in clinical research. Biased AI tools can lead to skew...